@JM12
"The market doesnt see value or understand the story sufficiently"
Or, it's simply a case of the market isn't willing to take a risk, (and there's still an element of risk), of buying and holding for 2-3 years to see if Ph3 trials are successful. Maybe, that will change the closer we get to finishing the trials.
Nash is right, management are doing what they can. They can hardly come out and say "Hey, we're the next CSL" or "2591 is Aspirin for the brain".
Real value will only come through successful trials, not spin.
Share Price, page-12137
-
- There are more pages in this discussion • 679 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.27 |
Change
1.000(8.15%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.39 | $12.79 | $9.854M | 751.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2545 | $13.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.29 | 1443 | 2 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |